One-stop Solutions for Nucleic Acid Drug Formulation Development

Nucleic acid drugs can directly target disease-causing genes or mRNA to cure diseases at the molecular level. Compared with traditional small molecule drugs and antibody drugs, nucleic acid drugs can fundamentally regulate the expression of pathogenic genes, and have obvious advantages such as high specificity, high efficiency and long-term performance. The development of nucleic acid drugs has experienced a long history, but with many advantages and accelerated development, nucleic acid drugs are also facing various challenges. CD Formulation nucleic acid drug development platform is an integrated comprehensive platform integrating drug discovery, production and preclinical research. Based on rigorous scientific attitude, open technology platform and advanced instruments and equipment, we can meet the industry's research and development needs for cutting-edge innovative nucleic acid drugs, undertake nucleic acid drug discovery, screening and preclinical research services of pharmaceutical companies and scientific research institutions, and provide one-stop formula solutions for your nucleic acid drug development.

Our Services Include But Not Limited to:

• Full Process Solution for Nucleic Acid Drugs

Popular nucleic acid drugs, such as siRNA, ASO, miRNA, Aptamer, etc., function based on the RNAi process and offer various advantages, including unlimited target druggability, high specificity, long half-life, faster and more efficient design, development and production process. With years of experience in DNA and RNA oligonucleotide synthesis, we have developed an integrated siRNA & ASO production platform that streamlines sequence design, synthesis, delivery, and bioassay screening to support and accelerate your nucleic acid drug development projects.

• Nucleic Acid Drug Synthesis & Modification

CD Formulation nucleotide drug chemical synthesis platform can provide one-stop monomer synthesis and modification, oligonucleotide synthesis, delivery system synthesis and oligonucleotide conjugate synthesis. The established siRNA library not only has a rich monomer inventory, but also has a large monomer synthesis block library, which can quickly complete the synthesis of various modified monomers. Our have a professional R&D team of nucleic acid drugs to provide efficient and fast R&D services.

• Analytical Services

Our analytical capabilities cover the whole spectrum from DNA, RNA and LNPs. We support analytical development from discovery to bridging capabilities for preclinical and clinical processes, up to quality control during GMP manufacturing. Including development of new analytical methods, routine analysis of R&D samples based on our standard analytical qualified methods catalog, analysis of GMP samples based on our QC's validated method catalog.

Our Advantages of Our Services

• We have been in the nucleic acid drug field for many years and have rich project development experience in the industry, which can provide one-stop research and full project management services.
• We provide compliant, high quality, reliable and efficient service to help partners shorten the R&D cycle, reduce trial and error costs, accelerate product registration and market launch.
• Our one-stop service reduced human resources and operating costs.
• Our one-stop service is convenience and speed, and including all the raw data for subsequent testing and optimization.

If you have any nucleic acid drug requirements, please contact us by phone or email, our colleagues will reply to you within three working days.